Edward Berg
Förmögenhet: 456 998 $ per 2026-06-30
Förmögenhet: 456 998 $ per 2026-06-30
Edward B. Berg is General Counsel & Senior Vice President at Vaxart, Inc. since 2022.
Former roles include Vice President & Deputy General Counsel at BioMarin Pharmaceutical, Inc. from 2018 to 2022; Deputy General Counsel-Pharmaceutical Operations at Sanofi-Aventis U.S.
LLC from 2008 to 2018; Vice President at Sandoz, Inc. from 2016 to 2018; Vice President-Legal at Novartis AG from 2016 to 2018; Senior Corporate Counsel-Research & Development at Bristol Myers Squibb Co. from 2006 to 2008; and Senior Attorney & Associate Counsel at Merck & Co., Inc. from 1993 to 2001.
Education includes undergraduate studies at the University of Washington and graduate studies at The University of Pennsylvania Law School.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VAXART, INC. 0,31 % | 2026-03-24 | 755 368 ( 0,31 % ) | 456 998 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| VAXART, INC. | Generell Rådgivare | 2022-02-14 |
| Företag | Position | Slut |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Företagsledare/Principal | 2022-02-01 |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Företagsledare/Principal | 2018-06-01 |
| NOVARTIS AG | Generell Rådgivare | 2018-06-01 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Företagsledare/Principal | 2018-06-01 |
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | 2008-08-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
The University of Pennsylvania Law School
The University of Pennsylvania Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxart, Inc.
Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån